The subject of this publication is the conclusion of non-exclusive agreements on various contrast agent / drug combinations in an open-house procedure, which are prescribed and delivered to the health insurance in Rhineland-Palatinate and the Saarland SSB. More details on the active substances concerned can be found in Annex 11 to this publication. Contrast media from any future contractor may be ordered by the contracted physicians who are informed about these economic sources of supply during the contract period, on the basis of the efficiency requirement; they are considered economical. Contract doctors are obliged to fulfill their demand for contrast agents from a specialist group with the products of the contracting partner or one of the contractual partners. There is a fixed, non-negotiable contract price for each section.

Name: Nonionic iodine-containing monomeric low-osmolar water-soluble nephrotropic X-ray contrast media.

Application: Intra-arterial and intravenous and intracavitary. Further possible.

Application areas:

- urography,

- Computed Tomography,

- angiography,

- digital subtraction angiography (DSA),

- angiocardiography, coronary arteriography, interventional coronary arteriography,

- Fistulography, galactography.

Active Ingredient / Combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or more possible.

Pharmaceutical forms: All approved dosage forms of an active substance must be offered.

Concentration: 400 mg / ml.

Pack size: All authorized pack sizes of one active substance must be offered.

Further information can be found in Annex 11 to the call for proposals.

Name: Nonionic iodine-containing dimeric low-osmolar water-soluble nephrotropic X-ray contrast media.

Application: Intra-arterial and intravenous. Further possible.

Application areas:

- Cerebral angiography, abdominal angiography, peripheral arteriography, venography,

- urography,

- Contrast enhancement in computerized tomography (CT).

Active Ingredients / Combinations (ATC): Iodixanol (V08AB09) and / or others possible.

Pharmaceutical forms: All approved dosage forms of an active substance must be offered.

Concentrations must be offered cumulatively:

1 270 mg / ml (all concentrations of one active substance must be offered)

2 320 mg / ml (all concentrations of one active substance must be offered)

(at least together, all application areas must be covered).

Pack size: All authorized pack sizes of one active substance must be offered.

Further information can be found in Annex 11 to the call for proposals.

Name: Paramagnetic extracellular linear contrast agent for MRI.

Application: Intraarticular application.

Indications: Direct magnetic resonance arthrography.

NSF risk: high NSF risk class.

Active Ingredients / Combinations (ATC): Gadopentetic Acid (V08CA01).

Dosage Forms: All dosage forms of the active substance for this indication.

Concentration: 0.002 mmol / ml.

Pack size: All pack sizes of the active substance for this indication.

Further information can be found in Annex 11 to the call for proposals.

Name: Paramagnetic extracellular macrocyclic contrast agent for MRI.

Application: Intraarticular application.

Indications: Direct magnetic resonance arthrography.

NSF Risk: Low NSF Risk Class.

Active Ingredients / Combinations (ATC): Gadoteric acid (V08CA02).

Dosage Forms: All dosage forms of the active substance for this indication.

Concentration: 0.0025 mmol / ml.

Pack size: All pack sizes of the active substance for this indication.

Further information can be found in Annex 11 to the call for proposals.

Name: Paramagnetic extracellular linear contrast media for MRI with renal excretion and partial biliary excretion.

Application: Intravenous. Further possible.

Indications: MRI of the liver.

NSF risk: Mean NSF risk class.

Active Ingredients / Combinations (ATC): gadobenic acid (V08CA08).

Pharmaceutical forms: All authorized dosage forms of an active substance.

Concentration: All concentrations possible.

Pack size: All authorized pack sizes of the active substance.

Further information can be found in Annex 11 to the call for proposals.

Name: Paramagnetic combined extracellular and hepatobiliary linear contrast media for MRI (excretion 50-50).

Application: Intravenous use. Further possible.

Indications: MRI of the liver.

NSF risk: Mean NSF risk class.

Active Ingredients / Combinations (ATC): Gadoxetic acid (V08CA10).

Dosage forms: All dosage forms of the active substance.

Concentration: all concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Annex 11 to the call for proposals.

Name: Barium sulphate-containing contrast agent.

Application: Oral and / or intestinal and / or rectal use.

Areas of application: Presentation of parts of the digestive tract and / or the entire digestive tract by CT and / or X-ray, further possible.

Active Ingredients / Combinations (ATC): Barium Sulfate (V08BA).

Dosage forms: All dosage forms of the active substance.

Concentration: All concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Annex 11 to the call for proposals.

Designation: Ultrasonic contrast agent.

Application: Intravenous use.

Indications: Echocardiography, others possible.

Active Ingredients / Combinations (ATC): All active ingredients of ATC Group V08DA possible.

Dosage forms: All dosage forms of the active substance.

Concentration: All concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Annex 11 to the call for proposals.